Referrals, access, and equity of monoclonal antibodies for outpatient COVID-19: A qualitative study of clinician perspectives

Neutralizing monoclonal antibody treatments for non-hospitalized patients with COVID-19 have been available since November 2020. However, they have been underutilized and access has been inequitable. To understand, from the clinician perspective, the factors facilitating or hindering monoclonal anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamer, Mika K., Alasmar, Ahmed, Kwan, Bethany M., Wynia, Matthew K., Ginde, Adit A., DeCamp, Matthew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771255/
https://www.ncbi.nlm.nih.gov/pubmed/36550877
http://dx.doi.org/10.1097/MD.0000000000032191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771255/
https://www.ncbi.nlm.nih.gov/pubmed/36550877
http://dx.doi.org/10.1097/MD.0000000000032191

Ejemplares similares